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ABSTRACT       A case-control study of breast  cancer was 
conducted in Buffalo. Participants completed a food frequency 
questionnaire and donated a fasting blood sample before de- 
finitive workup for breast masses. Dietary and plasma concen- 
trations of carotenoids and retinol for 83 women found to have 
breast cancer were compared with those of 1 13 women found 
to be free of breast cancer (control subjects). There were no 
case-control differences in dietary estimates of vitamin A in- 
take or in plasma a-carotene and lycopene. However, subjects 
with breast cancer had lower concentrations of plasma fj-caro- 
tene than did control subjects (P = 0.02). There was no overall 
association between plasma retinol and breast cancer but a pos- 
itive relationship was observed between retinol and breast can- 
cer in the subgroup with low fj-carotene values. These results 
suggest that low plasma fj-carotene is associated with increased 
risk of breast cancer. Other studies will need to determine 
whether low carotene concentrations are a subtle effect of the 
disease or might be causally related to breast cancer.  
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Introduction 
The roles of vitamin A and carotenes in carcinogenesis have 
been investigated in a large number of experimental systems 
( I ). Supplemental  retinyl acetate in animal diets may cause 
either a lower (2-8) or higher (9) incidence of mammary tu- 
mors whereas supplemental fj-carotene in the diet was shown 
to inhibit mammary tumors (10, 1 1) and transplantable tu- 
mors ( l 2). 
butions from both  preformed  (retinol) and precursor  (caro- 
tenes) vitamin A. Although results from some plasma studies 
( 16, 20) indicated no association between breast cancer and fJ· 
carotene or total carotenoids. respectively, results from other 
blood studies ( 19, 25. 26) showed a nonsignificant inverse asso- 
ciation between breast cancer and fj-carotene. 
Overall, previous studies indicate either no association or a 
direct association between breast cancer and retinol and no as- 
sociation or an inverse association between carotenes and 
breast cancer. Some studies were not specifically designed to 
investigate breast cancer and suffered from inadequate power 
(19-21. 25) whereas others did not control for important 
breast  cancer risk factors (20. 21, 23, 25. 26) or plasma lipids 
(19. 21, 25, 26). These limitations may have diminished the 
ability to observe the effects of nutrients on cancer risk. 
This case-control study was designed to assess the indepen- 
dent and interactive effects of preformed vitamin A and carot- 
enoids in the plasma and in the diet, controlling for other risk 
factors and other nutrients. 
 
Methods 
 
Between September 1985 and September 1986, study sub- 
jects were enrolled from the breast clinic at Roswell Park Me- 
morial Institute and from the offices of two private surgeons in 
Buffalo. Eligible patients were women aged 30-80 y who were 
being evaluated for a breast mass but who had no previous his- 
tory of cancer. All participants had lived in upstate New York 
or Pennsylvania for I y. After subjects were scheduled for a 
diagnostic biopsy, informed consent was obtained and they 
were given a questionnaire and directions for the blood-collec- 
 
 
 
Epidemiologic studies have indicated an inverse association    
between plasma retinol and risk of cancer of all sites ( 13, 14), 
with only suggestive evidence for this association  in  breast  can- 
cer ( 15). Three studies with dietary data ( 16-18)and three stud- 
ies with plasma data (19-21) showed no association between 
breast cancer and retinol whereas one study with plasma 
showed a positive association ( 16). 
An inverse association was observed between breast cancer 
and estimates of dietary intake of carotenes ( 17)and vegetables 
(22). One dietary study ( 18) showed no association whereas 
other dietary studies (23, 24) reported an inverse association 
between breast cancer and total vitamin A intake, with contri- 
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tion procedure. The study was approved by the Clinical Investi- 
gations Committee at Roswell Park Memorial Institute and by 
Institutional Review Boards at the State University of New 
York at Buffalo and the Buffalo General Hospital. Thirty-four 
patients who were referred to the specialists because of a suspi- 
cious mammogram or lump but were determined not to have 
masses requiring biopsy were included in the control group. 
Patients were classified into one of three groups on the basis 
of their pathology reports from the breast biopsies: subjects 
with breast cancer ( n = 83), control subjects ( n = 1 13), or ex- 
cluded (n = 40). Women with breast cancer had cancers classi- 
fied as 7% in situ, 32% stage I, 46% stage II, and 15% stages III 
or IV. The 1 13control subjects were those 79 women who were 
found to have benign lesions on biopsy , plus the 34 women 
who did not require a biopsy . The 40 patients with biopsy re- 
ports that described lesions and who were thought to be at in- 
creased risk of breast cancer (predominantly of an atypical hy- 
perplastic nature) were excluded from the control group. 
The self-administered questionnaire requested information 
about the subjects' dietary practices and medical history. A 
food frequency table with five frequency categories (never, 
rarely, 1-3 times/mo, 1-4 times/wk, and 5-7 times/wk) con- 
tained a list of 30 food items that previous analysis indicated 
would account for 90% of the variance associated with esti- 
mated vitamin A intake (27). Standard portion sizes were as- 
sumed to convert the frequency data into estimates of nutrient 
intake. 
Fasting blood samples were drawn from subjects before their 
biopsies were taken or on a designated day for the 34 patients 
who did not have biopsies taken . The samples were centrifuged 
at 2000 X g for 12 min and plasma was preserved in sodium 
ascorbate ( I 0 mg/mL plasma) and frozen at -80 °C until the 
end of the study. Blood was stored from 5 to 17 mo; storage 
duration was similar for women with breast cancer and control 
subjects. In addition, there were no trends observed concerning 
nutrient concentrations with length of storage. Blood speci- 
mens were thawed once for portioning of samples and once for 
the laboratory analysis. Retinol and carotenoids were analyzed 
by HPLC, retinol by a modification of a standard method (28), 
and carotenoids by a modification of a new method (29). 
 
Statistical analysis 
 
Statistical analyses were conducted with SYSTAT (version 
3.0, Systat, Inc, Evanston, IL) and the supplementary logit pro- 
gram on an AT&T 6300 personal computer. Differences in 
means were tested with the Student's t test and differences in 
proportions were tested by logit analysis. In the latter analyses, 
case status was the independent variable, the breast-cancer risk 
factor was the dependent variable, and other breast-cancer risk 
factors were added to the model as needed. Nutrients were log- 
transformed and categorized into quartiles on the basis of their 
distribution in the control subjects. Multivariate analyses used 
logit analysis with case status as the dependent variable; there 
were three possible outcome categories but only the results for 
subjects with breast cancer vs control subjects are presented 
here. In the multivariate analyses the nonnutrient, breast-can- 
cer risk factors used as covariates were age, age at menarche, 
age at menopause, age at first birth, parity, menopausal status, 
family history of breast cancer in a first-degree relative, 
Quetelet index (kg/m 2),  marital status, and income. Analyses 
 
TABLE I 
Descriptive statistics of potential confounding variables for subjects 
with breast cancer and control subjects• 
 
 
Breast-cancer Control 
patients subjects 
(n = 83) ( n = 1 13) 
 
Age (y) 57.78 ±  1 1.0lt 50.47 ± I0.81 
Weight (kg) 69.79 ± 13.49 67.85 ± 12.00 
Height (cm) 164.75 ± 7.33 165.19 ± 7.93 
Quetelet index (kg/m 2) 25.82 ± 5.16 24.89 ± 4.52 
Age at menarche (y) 12.83 ± 1.30 12.70 ± 1.57 
Age at first birth (y) 23.43 ± 3.95 23.37 ± 4.29 
Parity 3.03 ± 1.36 3.36 ± 1.63 
Age at menopause (y) 47.66 ± 6.27 47.02 ± 5.92 
Duration of breast-feeding (mo)t 5.21 ± 9.01 6.70 ± I0.47 
Menopausal (%)§ 66 57 
Surgical menopause (%)11 40 33 
Family history of breast cancer (%) 28 39 
Married (%) 71 87 
Never married (%) 13 9 
Widowed (%) 16 4 
Nulliparous (%) 16 17 
History ofBBD (%) 29 40 
Two highest income groups (%)"* 29 42 
 
 
•x ± SD. BBD, benign breast disease. 
t Significantly different from control subjects, P < 0.00 I . 
* Total months in lifetime spent breast-feeding. 
§ Percent of diagnostic group. 
U Percent of those menopausal. 
Self-reported history of a previous diagnosis of BBD. 
•• Two highest of seven income categories. 
 
 
of the plasma retinol and carotenoid variables also controlled 
for plasma lipids to evaluate the effect of the nutrient of interest 
after differences in lipid status were eliminated. In addition, 
both triglycerides and cholesterol were associated with case sta- 
tus and therefore were potential confounding variables. Tests 
for trend used the continuous, log-transformed nutrient vari- 
able. The models and variables were assessed by use of the log 
likelihood ratio test and all significant predictors of case status 
were included in the full models, as well as the nonnutrient, 
breast-cancer risk factors. 
 
Results 
 
The characteristics of the subjects with breast cancer and 
control subjects at baseline are presented in Table 1. Subjects 
with breast cancer were significantly older than the control sub- 
jects but were not statistically different from control subjects in 
any of the other potentially confounding variables. Subjects 
with breast cancer had significantly lower P-carotene and lyco- 
pene values than did control subjects (P < 0.01 and P < 0.05, 
respectively) (Table 2); however, they did not have different 
mean values for retinol, a-carotene, or dietary estimates of vita- 
min A intake. 
Multivariate analysis showed that low P-carotene was associ- 
ated with an increased risk of breast cancer, with and without 
adjustment for plasma lipids (Table 3). Further analyses 
showed that the inverse association between P-carotene and 
breast cancer was restricted to the postmenopausal cases (test 
for trend P < 0.00 I ). Alpha-carotene was not associated with 
breast-cancer risk (Tables 2 and 3), and low concentrations of 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 2 
Comparison of plasma and dietary variables among subjects with 
breast cancer and control subjects* 
nificant. Although the  other confidence intervals included 
unity, the trends indicated that within the other P-carotene 
quartiles, risk decreased as retinol increased. 
 
 
 
 
Plasma 
Retinol (µmol/L) 
P-carotene (µmol/L) 
a-carotene (nmol/L) 
Lycopene (nmol/L) 
Diet 
Total vitamin A (IU/d) 
Breast-cancer 
patients 
(n = 81) 
 
 
1.95 ± 0.62 
0.21 ± 0. 16 
57 ± 41 
417 ± 188 
 
1 1 900 ± 6 800 
Control 
subjects 
(n = 101) 
 
 
1.93 ± 0.44 
1.26 ± O. t 5t 
64 ± 37 
491 ± 238t 
 
12 300 ± 6 800 
Multivariate analyses of the dietary data indicated no associ- 
ation between breast cancer and either total or vegetable vita- 
min A intakes (Table 5). There was no statistically significant 
interaction between total vitamin A and vegetable vitamin A. 
Total dietary vitamin A was not correlated with plasma reti- 
nol ( r = 0.1 1) or P-carotene ( r = 0.16), nor was dietary vitamin 
A from vegetable sources correlated with plasma P-carotene ( r 
= -0.02). Plasma a-carotene, however, was marginally corre- 
lated with total dietary vitamin A ( r = 0.26). 
     Vegetable vitamin A (IU/d) I770 ± 2 400         1 900 ± 2 900 
 
* x ± SD. 
tt Significantly different from cases: tP < 0.01, tP < 0.05. 
 
lycopene appeared to be associated with increased risk of breast 
cancer before controlling for plasma lipids. Lycopene was not 
associated with case status after controlling for these lipids. 
The main effect of plasma retinol values indicated no associ- 
ation with breast-cancer risk (Table 3); however, a statistically 
significant interaction with plasma P-carotene (Table 4) 
showed a trend of increasing risk for breast cancer with increas- 
ing retinol within the low P-carotene quartile. The wide confi- 
dence intervals indicated few individuals with higher retinol 
and low P-carotene; even so, the results were statistically sig 
 
 
TABLE 3 
Discussion 
Control group 
Many of the known breast-cancer risk factors were not more 
prevalent among subjects with breast cancer than among con- 
trol subjects. Therefore, these control subjects would appear to 
be at high risk for breast cancer, according to known risk-factor 
classification for breast cancer, if they were compared with 
women in the general population. Thus, this study compared 
women with breast cancer with a group who had similarly high 
risk but who did not have breast cancer. 
There are two possible biases of concern with this control 
group. The results may be biased towards a false-positive find- 
ing if the breast-cancer risk factors prevalent in this control 
group were also associated with nutrient status (eg, high carot- 
 
 
Odds ratios (subjects with breast cancer vs control subjects) for plasma nutrient quartiles with adjustments for potential confounding variables 
with and without lipid adjustment* 
 
 
Quartilest 
 
 
Nutrient QI Q2 Q3 Q4 pt 
Lipid  unadjusted 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
 
* Full model included age, age at first birth , family history, age at menarche, Quetelet index, parity. age at menopause , income, and marital 
status. Lipids include plasma cholesterol and triglyceride . 
t Qt is low and Q4 is high. 
t Significance of trend. 
§Odds ratio of quartile compared with the fourth quartile. 
II 95% confidence limits. 
11 Full model also contained P-carotene. 
 P-Carotene 4.42§ t.90 1.41 1.00 <0.01 
 ( 1.33. 14.7)11 (0.55, 6.55) (0.43, 4.64)   
a-Carotene 2.69 1.12 0.96 1.00 0.18 
 (0.88. 8.23) (0.36, 3.51) (0.31.2.99)   
Lycopene 2.40 2.45 1.55 1.00 0.09 
 (0.83, 6.95) (0.87, 6.93) (0.51, 4.72)   
Retinol I.II 1.21 0.64 1.00 0.67 
 (0.38, 3.26) (0.41. 3.55) (0.23. 1.83)   
Lipid adjusted      
P-Carotene 3.15 1.79 1.18 1.00 0.02 
 (0.90, I 1.04) (0.50, 6.39) (0.34, 4.09)   
a-Carotene1! 0.63 0.45 0.61 1.00 0.19 
 (0.13, 2.95) (0.1 I , 1.80) (0.18, 2.06)   
Lycopene t.60 1.94 1.39 1.00 0.43 
 (0.50, 5.18) (0.64, 5.88) (0.45. 4.32)   
Retino11l 1.06 1.01 0.60 1.00 0.41 
 (0.31. 3.64) .32, 3.25) (0. 18, I.97)   
 
 
 
TABLE 4 
Case-control adjusted odds ratios for the retinol, by ,8-carotene 
interaction• 
 
 
{:I-carotene quartiles 
 
 
 
Retinol levelt Q I Q2 Q3 Q4 
Low ( 25th 3.41 4.07 3.64 3.85 
percentile) (0.75. 1 5.6)§ (0.90. 18.5) (0.66. 20.1) (0.84, 17.6) 
 (9. 7)11 (5. 5) (5. 3) (4, 4) 
Median (50th 5.50 2 .90 1.92 1.92 
percentil e) ( 1.30. 23.2) (0.71. 1 1.9) (0.45. 8.21) (0.92, 4.00) 
 (14. 14) (9. 14) (9. 14) (4. 10) 
High (75th 8.58 2 .1 1 1.06 1.00 
percentile) ( 1.82. 40.5) (0.48. 9.30) (0.23. 4.91 )  
 (12. 4) (3. 6) (4. 8) (3. 8) 
• Odds ratios adjusted for cholesterol, triglyceride . tl<arotene. the 
retinol-by- tl-carotene interaction. age. age at first birth, family 
history. age at menarche. Quetelet index. parity. age at menopause, 
income, and marital status. 
t Percentile based on ranking ofall study subjects. Low, 0.81 
µmol/L; median. 
0.98 µmol/L: high.  1 .17 µmol/ L. 
t QI is low and Q4 is high. 
§ 95% confidence limit. 
II Number of cases.control subjects. 
Reference  group. 
 
 
enoid consu mption). No evidence was found supporting an as- 
sociation between the benign breast disease prevalent in this 
control group and vitamin A or carotenoids (30), and it is un- 
likely that other components of the high-risk classification (eg, 
age at menarche, age at first birth) are related to these nutrients. 
In contrast. the control subjects were very similar to subjects 
with breast cancer, by risk-factor  classification  which  would 
bias the results towards a false-negative finding of no associa- 
tion. This is only of concern with  the findings for a-carotene 
and lycopene. which were nonsignificant , but is not of concern 
with findings for ,B-carotene and retinol, which were significant. 
Indeed , the similarity between the groups may be a strength of 
the study because the analysis focused on factors that allowed 
control subjects to be free of cancer even though they were very 
similar to subjects with breast cancer in terms of other risk fac- 
tors. A difference in nutritional status between these two groups 
would be of considerable interest because it would suggest a 
nutritional advantage among the control subjects very  late in 
the promotional stages of the disease process. These results not 
only indicated that such a difference existed between these 
groups but also that the difference was in the same direction 
(low ,B-carotene, higher risk) as that frequently observed in ear- 
lier etiologic stages. 
Plasma ,B-carotene 
The concentrations of carotenoids in this study were rela- 
tively low compared with those in similar groups of women in 
the United States (31, 32). Quality control plasma samples were 
exchanged between laboratories, which determined that our as- 
say yielded values approximately one-half the values obtained 
by other standard methods (33, 34) because oflower extraction 
efficiency of the solvent. There was no evidence of differential 
loss by concentration of carotenoids, rather a loss of -50% at 
all concentrations. Therefore, the ordinal ranking of individu- 
als would be similar to that provided by the higher absolute 
values. Carotene values are reported here in the original form 
because relative and not absolute values were used to support 
these types of statistical analyses. 
The association of lower ,B-carotene concentrations with 
breast cancer may be confounded by alcohol intake, which was 
not measured in this study. Alcohol was associated with breast 
cancer in 12 studies (35-46) but not in 5 other studies (47-51). 
In addition, alcohol may be associated with lower plasma ,B- 
carotene values (32, 52) although this effect has only been ob- 
served in men and it is unclear whether alcohol is directly re- 
lated to lower ,B-carotene concentrations or is coincident with 
lower ,B-carotene intake. Further research is warranted to deter- 
mine whether the association of plasma ,B-carotene values with 
breast cancer persist after controlling for alcohol consumption. 
Although smoking has been associated with lower plasma ,B- 
carotene (32, 52), it has not been associated with breast cancer 
(53) and therefore was not controlled in the analyses. 
Lower plasma ,B-carotene values in the breast-cancer patients 
may also be a result of rather than a precursor of disease. A 
marginally significant trend (P = 0.08) of decreasing ,B-carotene 
values with increasing stage of disease was observed; this sug- 
gests that the disease may alter this blood variable. Alterna- 
tively, the patients with later-stage disease may have altered 
their intake to a greater degree than did the patients with ear- 
lier-stage disease. Although it is difficult to disentangle such re- 
sults in a case-control study, there is some evidence from other 
studies against a metabolic alteration due to the disease. A pro- 
spective study in Britain ( 19) demonstrated that the subjects 
with breast cancer diagnosed within 2 y of blood collection did 
not have lower ,B-carotene concentrations than did subjects di- 
agnosed later. In addition, there is no evidence from animal 
studies that tumors affect the concentrations of this nutrient 
whereas there is evidence that low ,B-carotene intake promotes 
mammary tumors ( I 0). However, further studies are needed to 
elucidate the possible affect of the disease on ,B-carotene con- 
centrations. 
Plasma ,B-carotene was shown to reflect dietary intake of ,B- 
carotene (26, 54, 55) and total carotene intake (32, 52, 56); 
therefore, the lower ,B-carotene concentrations observed to be 
associated with case status may be of dietary origin. Although 
the dietary data from this study did not support this conclusion, 
results from larger dietary studies indicated that lower esti- 
mated intakes of total vitamin A (23) or ,8-carotene (17) were 
 
TABLE 5 
Odds ratios (subjects with breast cancer vs control subjects) for dietary 
nutrient quartiles with adjustments for potential confounding 
variables in the full model* 
 
 
 
Nutrient 
Total 
vitamin A 
Vegetable 
 
 
vitamin A    (0.44,3.67)                (0.66,4.48)          (0.50,4.36) 
 
 
 
        Adjusted for age, age at first birth, family history. menarche, 
Quetelet index, parity, age at menopause , income, and marital status. 
t QI is low and Q4 is high. 
t Reference group. 
§ Significance of trend. 
II Odds ratio of quartile compared with the fourth 
quartile. 95% confidence limits. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Quartiles  
 
QI 
 
Q2 
 
Q3 Q4t 
 
P§ 
1.3511 1.43 0.45 1.00 0.56 
(0.50, 3.60)11 (0.53, 3.87) (0. 14, 1.45)   
1.27 1.72 1.48 1.00 0.52 
     
(   
  
 
 
associated with breast cancer. Vitamin supplements were not 
considered in this study because only six women reported tak- 
ing /j-carotene supplements and the common multiple-vitamin 
supplement did not contain (j-carotene at the time of data col- 
lection. 
There have been four other investigations of breast cancer 
that have measured plasma carotene values. In a prospective 
study in England ( 19) the authors found lower plasma P-caro- 
tene values (NS) in women later diagnosed with breast cancer 
than in women who remained disease free. Although these 
findings were later questioned because of storage considera- 
tions (57), the present study corroborates these findings. In a 
preliminary report (26) the mean plasma Jj-carotene concentra- 
tion of 30 women with metastatic breast cancer was 21% lower 
than in control subjects. Willett et al (20) did not find an associ- 
ation between breast cancer and plasma carotenoids; however. 
this study was limited by sample size ( n = 14 cases) and did not 
control for important confounding factors. In a case-control 
study in Italy ( 16), the authors did not find an association be- 
tween breast cancer and plasma P-carotene values. The mean 
P-carotene values were relatively high in this population, which 
suggests that there were few individuals in the low range where 
the effect was observed in the present study (even if our values 
were doubled to allow for analytical extraction efficiency). 
 
Alpha-carotene and lycopene 
There was weak evidence of an association between a-caro- 
tene and the disease in the model that did not include Jj-caro- 
tene and lipids. However, the collinearity between P-carotene 
and a-carotene ( r = 0.71) made it difficult if not impossible to 
assess the independent a-carotene effect when both carotenoids 
were necessary in the full model. The larger range of Jj-carotene 
allowed it to predominate but this does not exclude the possi- 
bility of a contribution from a-carotene. 
Plasma lycopene values were associated with case status only 
before plasma cholesterol and triglycerides were controlled in 
the analysis. Adjustment for the these lipids allowed observa- 
tion of the independent effect of lycopene (or lack of an effect) 
after differences in lipid status and the association of the lipids 
with case status were eliminated. Stryker et al (32) demon- 
strated a better correlation between calorie-adjusted dietary in- 
take of fat-soluble nutrients (carotenoids and tocopherols) and 
the lipid-adjusted concentrations of these nutrients in plasma 
compared with the unadjusted concentrations. Therefore, the 
inference of risk estimates from plasma data to dietary intake is 
stronger after the plasma variables are adjusted for these lipids. 
 
Plasma retinal 
The higher risk observed with higher retinol within the low 
P-carotene quartile is consistent with studies  that associated 
breast  cancer with  low dietary  intake of total  vitamin  A (23, 
24) or P-carotene (17) and high plasma retinol (16). The sig- 
nificance of the high plasma retinol is u nclear, perhaps it is a 
marker of particular dietary habits or other metabolic factors. 
Retinol has been positively associated with plasma estrogens 
(58) and, because estrogens may be associated with promotion 
of breast cancer, higher retinol concentrations may merely be 
a marker for the estrogenic environment or, perhaps, part of 
the mechanism by which estrogens exert their effect. Nonethe- 
less, the pattern of risk observed suggests that P-carotene is not 
acting solely through its conversion to retinol. and that these 
two nutrients may have some interdependent functions in car- 
cinogenesis. The lack of a main effect of plasma retinol and the 
presence of an interactive effect between plasma retinol and P- 
carotene demonstrates the importance  of  evaluating  n utri- 
tional interactions in studies of cancer etiology. 
 
Dietary data 
The results from the dietary data were consistent with one 
study that did not find an association between breast cancer 
and dietary Jj-carotene (16). Other dietary studies (17, 23, 24) 
with larger sample sizes (451, 2024, and 120 cases. respectively) 
than the present study did show associations when dietary indi- 
cators of vitamin A or (j-carotene were used. 
The questionnaire used in this study was an abbreviated 
form of a larger food frequency questionnaire. Although indi- 
viduals should rank approximately the same by the use of either 
questionnaire, the abbreviated questionnaire may be more 
prone to misclassification than the more complete question- 
naire. This misclassification would have more impact on small 
studies and therefore could account for the lack of findings. 
Preliminary analysis of the reproducibility of the dietary data 
from this study suggests poor agreement in frequency catego- 
ries between first and second questionnaires (59% exact agree- 
ment, 71% agreement plus or minus one frequency category). 
Thus, these dietary data included a large amount of variability 
that was unaccounted for, which biased the results toward the 
null hypothesis. The positive findings when the plasma indica- 
tors were used, the lack of a correlation between the plasma 
and dietary indicators of vitamin A, and the lack of reproduc- 
ibility of the dietary data suggest that dietary indicators were 
not as sensitive as were plasma indicators. Therefore, a larger 
sample size would be required for the food frequency method- 
ology employed here to be useful. 
In conclusion, the findings concerning P-carotene are in ac- 
cord with studies that found an association between low Jj-caro- 
tene concentrations and cancers of epithelial origin (59). It is 
important to note, however, that high plasma P-carotene may 
also be a marker for carotene-rich foods so that other carotenes, 
or other constituents of these foods, may be the more impor- 
tant risk factors. Low plasma P-carotene in combination with 
high retinol was found to be associated with breast cancer, 
which was consistent with diets low in carotene-containing veg- 
etables and may be a marker of a dietary pattern. These findings 
are consistent with the National Research Council's (60) di- 
etary recommendations for increased consumption of fruits 
and vegetables. As interest in the association between nutrition 
and cancer rises (61 ), additional studies of this type will be war- 
ranted. 0 
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